Bioassay and NMR-guided fractionation of the methanolic extract of Rhododendron decorum leaves resulted in the isolation of two new flavonoid glycosides, 5,7-dihydroxy-6,8-dimethyldihydroflavanone-7-O-α-L-arabinopyranosyl(1→6)-β-D-glucopyranoside (decoroside A, 1) and its 3-hydroxy congener (decoroside B, 2), along with five known compounds myricitrin (3), afzelin (4), (-)-epicatechin (5), (+)-catechin (6), and ampeloptin (7). The structures of the isolated compounds were elucidated by extensive interpretation of their spectral data. Biological evaluation using the 3-(4,5-dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide (MTT) assay revealed promising cytotoxic activities of these compounds against different cancer cell lines.
Natural products are the most reliable source of new anticancer entities. Around 63% of anticancer drugs introduced over the last 25 years are either natural products or inspired by natural products. Natural products represent the most important sources for drug discovery. Higher plants are considered one of the foremost sources of therapeutic agents for mankind, and of about 270,000 terrestrial plants that have been taxonomically classified, ca. 10,000 are used for medicinal purposes [1] . Moreover, approximately 200,000 secondary metabolites of plant origin have been reported to date [2] . However, as the rate of re-isolation of plant secondary metabolites has significantly increased in the last two decades, the use of advanced spectral techniques and database dereplication has had a great impact by reducing re-isolation and simplifying the finding of new metabolites in plant extracts for further purification.
Since the weather conditions have a great impact on secondary metabolite profile [3, 4] , we decided to screen some extracts from northern Scottish plants for their cytotoxicity and dereplicated the active hits for new secondary metabolites using NMR spectroscopy. During this process, we came across an extract with high activity from a species of the genus Rhododendron. The genus Rhododendron, which contains about 850 species, is one of the main genera in the family Ericaceae, distributed in the Northern Hemisphere, mainly in Asia. For decades, the dried stems, leaves, and flowers of some Rhododendron species have been used in traditional medicine to treat diseases such as asthma, and also as an expectorant, analgesic and anti-inflammatory [5] . Screening of this genus for secondary metabolites started at late 1960s, and, in particular, during the last 20 years the phytochemical investigation of Rhododendron has resulted in the isolation and characterization of more than 200 secondary metabolites of different chemical classes, mainly flavonoids and diterpenoids [5] . R. decorum is a woody perennial tree, grown as an ornamental plant. Previous investigation of this species has led to the isolation of different secondary metabolites, especially flavonoids of diverse subclasses as well as diterpenoids of the grayanane type [6] [7] [8] . So far, there are few reports regarding the cytotoxic activity of the secondary metabolites isolated from this genus against different cancer cell lines [5] . Therefore, the ultimate objective of this study was to isolate and identify the bioactive components of this extract and assess their cytotoxic activity against different cell lines.
The methanolic extract of R. decorum leaves was selected based on cytotoxicity-guided screening. Application of different chromatographic techniques resulted in the isolation of two new flavonoid glycosides, farrerol-7-O-α-L-arabinopyranosyl(1→6)-β-Dglucopyranoside (decoroside A, 1), and its 3-hydroxy congener (decoroside B, 2), along with five known compounds, which, based on NMR spectroscopic interpretation, as well as comparison of their spectral characteristics with previously reported data, were identified as myricitrin (3) [9] , afzelin (4) [10] , (-)-epicatechin (5) [11] , (+)-catechin (6) [11] , and ampeloptin (7) [11] (Figure 1 ). corresponding to a C-ring of a flavanone. These data coincide with that of farrerol aglycone [11] . The 13 C NMR spectrum displayed 28 carbon resonances (Table 1) , of which 17 were virtually identical to those reported for farrerol [11] , while the remaining 11 resonances ( H 3.0-5.0) were indicative of the presence of a diglycoside with one hexose and one pentose moiety. 1 H and 13 C NMR data (Table  1) , together with assessment of the coupling constants, in addition to gCOSY ( Figure 2 ) and 1D TOCSY analyses suggested that the sugar moiety of 1 was identical to that of miconioside A, i.e. α-L-arabinopyranosyl-(1→6)-β-D-glucopyranose [12, 13] . The two sugar moieties were further confirmed by acid hydrolysis of 1 upon which β-D-glucopyranose and α-L-arabinopyranose were detected by co-chromatography on TLC in comparison with authentic sugar samples. Analysis of the HMBC spectrum ( Figure 2 (Figure 2 ). Comparing the optical rotation of the aglycone with the previously published data [12] indicated that the absolute configuration at C-2 of the aglycone was S. On the basis of these data, 1 was identified as (2S)-farrerol-7-O-α-Larabinopyranosyl(1→6)-β-D-glucopyranoside, representing a new secondary metabolite for which we propose the name decoroside A.
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HRESIMS analysis of compound 2 established its molecular formula as C 28 H 34 O 14 , which was 16 mass units higher than 1, indicating the presence of an additional oxygen atom in the form of a hydroxyl substituent. The 1 H and 13 C NMR data ( Table 1) showed that the CH 2 signal at position 3 in 1 was replaced by an oxygenated methine function ( H / C 4.67/72.0) in 2, while the coupling constant observed for H-3 (d, J = 11.7) indicating that the hydroxyl function was β-oriented. All remaining 1 H and 13 C NMR resonances were almost identical to those of 1. The absolute stereochemistry was assigned as 2R,3R, consistent with the previous discussion of compound 1, the coupling constant of H-3, as well as the previously published data of the same aglycone [14] . Table 2 , almost all compounds showed moderate to strong cytotoxicity against the four cell lines. Compound 3 showed a potent cytotoxic activity against the MCF-7 cell line, followed by 1, 2 and 4 ( Table 2 ). Compound 4 showed moderate cytotoxicity against all cell lines, except HT29, where it exhibited strong activity. On the other hand, compounds 1 and 2 showed strong cytotoxicity against both MCF-7 and A549, while compounds 5 and 6 showed either weak or no activity against MCF-7, Hep3B, and A549 cell lines ( Table 2 ). Based on these results, we could conclude that glycosylation plays a role in cytotoxic activity, while losing the glycosidic linkage diminishes the cytotoxic activities, especially against MCF-7 and Hep3B, which may play an important role in solubilization inside the cell line. On the other hand, loss of C=O, as in compounds 5 and 6, led to the loss of cytotoxic effect.
Bioactivity and NMR-guided isolation still play the major role in the discovery of new natural products. In this study, cytotoxicityguided isolation using different chromatographic techniques has led to the isolation of two new flavonoid glycosides, decorosides A-B, in addition to five previously isolated phenolic compounds. Weather conditions could have a great impact on secondary metabolite profiles as these two new metabolites were not traced before in the genus Rhododendron. The screened compounds showed moderate to strong cytotoxic activity against a panel of cancer cell lines.
